Breast and Gynecological Cancers: From Diagnosis to Prognosis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 150
Special Issue Editors
Interests: cancer imaging; imaging therapy; bioluminescent imaging; gene therapy; NMR- MRI; Oxygen/Hypoxia
2. Radiotherapy II Department, Institute of Oncology “Prof. Dr. Alexandru Trestioreanu”, 022328 Bucharest, Romania
Interests: breast cancer; gynecological cancer; angiogenesisi; glioma
Special Issue Information
Dear Colleagues,
Breast and gynecological cancers represent an imperative health problem because of their high incidence, mortality, and impact on patient quality of life. They are responsible for more than 40% of all cancers and 30% of all cancer mortality in women worldwide.
Major progress has been made regarding more accurate diagnostic tools and new treatment modalities in gynecological and breast cancers. Nevertheless, many open questions remain regarding early diagnosis, correct therapeutic options, and treatment sequences.
Implementing fully comprehensive diagnostic modalities and augmented surgical techniques and utilizing innovative new drugs alongside new radiotherapy procedures are priorities for continuously evolving and improving outcomes. This Special Issue aims to facilitate access to information for gynecologists, surgeons, medical oncologists, radiation oncologists, imaging specialists, and pathologists.
The paramount goal in managing these patients, along with survival, is to improve their quality of life; articles that discuss this aspect and new treatment modalities are essential for improving the standard of care.
Genetic factors play an important role in breast and gynecologic cancers, and we gladly welcome articles regarding their impact on biomarker research and precision oncology.
The submission of high-quality original articles, multidisciplinary works, and well-designed meta-analyses and reviews is encouraged to help gain better insights into the current knowledge regarding this topic and further research perspectives in the early diagnosis and management of breast and gynecological cancers.
Prof. Dr. Ralph Mason
Dr. Oana Gabriela Trifanescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- gynecological cancers
- cervical cancer
- endometrial cancer
- ovarian cancer
- vaginal cancer
- vulvar cancer
- precision medicine in gynecological cancers
